UCB SA (LON:0NZT)
225.40
-9.91 (-4.21%)
At close: Oct 31, 2025
UCB SA Market Cap
UCB SA has a market cap or net worth of 37.12 billion as of October 31, 2025. Its market cap has increased by 35.18% in one year.
Market Cap
37.12B
Enterprise Value
38.24B
Revenue
5.87B
Ranking
n/a
PE Ratio
32.51
Stock Price
225.40
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 747.38M to 37.12B, an increase of 4,867.25%. That is a compound annual growth rate of 13.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 37.12B | 23.11% |
| Dec 31, 2024 | 30.15B | 132.14% |
| Dec 29, 2023 | 12.99B | 4.81% |
| Dec 30, 2022 | 12.39B | -22.12% |
| Dec 31, 2021 | 15.91B | 11.28% |
| Dec 31, 2020 | 14.30B | 26.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| HSBC Holdings | 182.59B |
| Shell | 164.70B |
| Unilever | 114.25B |
| Rolls-Royce Holdings | 98.20B |
| Rio Tinto Group | 93.42B |
| British American Tobacco p.l.c. | 84.99B |
| GSK plc | 71.55B |